Molecular Partners AG buy melinda
Start price
09.05.17
/
50%
€26.20
Target price
09.11.17
€30.00
Performance (%)
-8.60%
End price
09.11.17
€23.94
Summary
This prediction ended on 09.11.17 with a price of €23.94. With a performance of -8.60%, the BUY prediction by melinda finished with a loss. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Molecular Partners AG | - | - | - | - |
| iShares Core DAX® | 2,55 % | -0,11 % | 15,00 % | 49,60 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % | 30,95 % | 80,87 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % | 49,70 % | 60,37 % |
| iShares S&P 500 | 1,93 % | -0,52 % | 24,88 % | 60,00 % |
Comments by melinda for this prediction
In the thread Molecular Partners AG diskutieren
Molekulare und Allergan: Rekrutierung für Patienten abgeschlossen abicipar Pegol
zu folgen
(Laufzeit überschritten)
Stopped prediction by melinda for Molecular Partners AG
Molecular Partners AG
Start price
Target price
Perf. (%)
€21.40
07.03.17
07.03.17
€24.50
24.03.17
24.03.17
5.97%
24.03.17
24.03.17
